PLoS ONE (Jan 2014)

Protein profiling of preeclampsia placental tissues.

  • Chang Shu,
  • Zitao Liu,
  • Lifeng Cui,
  • Chengguo Wei,
  • Shuwen Wang,
  • Jian Jenny Tang,
  • Miao Cui,
  • Guodong Lian,
  • Wei Li,
  • Xiufen Liu,
  • Hongmei Xu,
  • Jing Jiang,
  • Peng Lee,
  • David Y Zhang,
  • Jin He,
  • Fei Ye

DOI
https://doi.org/10.1371/journal.pone.0112890
Journal volume & issue
Vol. 9, no. 11
p. e112890

Abstract

Read online

Preeclampsia is a multi-system disorder involved in pregnancy without an effective treatment except delivery. The precise pathogenesis of this complicated disorder is still not completely understood. The objective of this study is to evaluate the alterations of protein expression and phosphorylations that are important in regulating placental cell function in preterm and term preeclampsia. Using the Protein Pathway Array, 38 proteins in placental tissues were found to be differentially expressed between preterm preeclampsia and gestational age matched control, while 25 proteins were found to be expressed differentially between term preeclampsia and matched controls. Among these proteins, 16 proteins and their associated signaling pathways overlapped between preterm and term preeclampsia, suggesting the common pathogenesis of two subsets of disease. On the other hand, many proteins are uniquely altered in either preterm or term preeclampsia and correlated with severity of clinical symptoms and outcomes, therefore, providing molecular basis for these two subsets of preeclampsia. Furthermore, the expression levels of some of these proteins correlated with neonatal small for gestational age (PAI-1 and PAPP-A) and adverse outcomes (Flt-1) in women with preterm preeclampsia. These proteins could potentially be used as candidate biomarkers for predicting outcomes of preeclampsia.